Background: Aim of this study was to search for any difference in the outcome of patients with adult onset Still's disease (AOSD) treated with anakinra (ANK) in relation with the interval between dise

NIAID Data Ecosystem20

Supplementary Table 1. Analysis of Variance (ANOVA) for Length of Stay by Admitting Service and Comorbidities.

化脓性汗腺炎临床管理

住院时间影响因素

Inpatient Management of Hidradenitis Suppurativa: A Single-Center Retrospective Study

NIAID Data Ecosystem00

Supplementary Material for: Infectious Disease Screening Prior to Systemic Immunomodulatory Therapy in Hidradenitis Suppurativa: Consensus Guidelines from the Asia-Pacific Hidradenitis Suppurativa Foundation

化脓性汗腺炎临床管理

免疫治疗前传染病筛查

Background: Current infectious disease screening recommendations for hidradenitis suppurativa (HS) are adopted from recommendations in chronic plaque psoriasis. No HS-specific guidelines for infectiou

Figshare2023-11-14 更新20

(Extended Version) North American Clinical Practice Guidelines for the Medical Management of Hidradenitis Suppurativa in Special Patient Populations

化脓性汗腺炎临床管理

特殊人群医疗指南

Extended version of manuscript entitled "North American Clinical Practice Guidelines for the Medical Management of Hidradenitis Suppurativa in Special Patient Populations" and other supplemental docum

Mendeley Data00

Supplementary Figure 2. Time from hospital discharge to initiation of biologics, stratifying for admitting service.

资源简介：

相关数据集